Q1 2023 Holdings
Filed 2023-05-12 | 22 holdings | $298.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amryt Pharma PLC - Spnr ADR | SPONSORED ADS | 03217L106 | $91.5M | 6,278,085 | 30.7% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $30.2M | 782,289 | 10.1% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $27.4M | 6,535,674 | 9.2% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $25.4M | 7,661,690 | 8.5% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $24.9M | 279,081 | 8.3% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $14.1M | 8,640,205 | 4.7% |
| Maxcyte Inc(MXCT) | COM | 57777K106 | $13.4M | 2,707,090 | 4.5% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $12.9M | 3,131,995 | 4.3% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $10.1M | 4,825,722 | 3.4% |
| Xoma Corp(XOMA) | COM NEW | 98419J206 | $6.7M | 318,096 | 2.3% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $6.7M | 292,866 | 2.2% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $6.5M | 701,535 | 2.2% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $5.9M | 3,087,649 | 2.0% |
| Evolus Inc(EOLS) | COM | 30052C107 | $4.9M | 578,795 | 1.6% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $4.1M | 416,519 | 1.4% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $3.7M | 370,000 | 1.2% |
| Travere Therapeutics Inc(TVTX) | NOTE 2.500% 9/1 | 89422G107 | $3.0M | 132,005 | 1.0% |
| Exagen Inc(XGN) | COM | 30068X103 | $2.5M | 1,037,074 | 0.8% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $2.3M | 684,508 | 0.8% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $1.4M | 450,000 | 0.5% |
| Conformis Inc(CFMSUSD) | COM NEW | 20717E200 | $648.3K | 402,651 | 0.2% |
| Cidara Therapeutics Inc | COM | 171757107 | $1.3K | 1,000 | 0.0% |